The Federal Policy for the Protection of Human Subjects announced revisions to modernize, strengthen, and make more effective the Federal Policy for the Protection of Human Subjects that was originally promulgated as a Common Rule in 1991. This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are an effort to modernize, simplify, and enhance the current system of oversight.
This compliance date for this rule is effective on January 20, 2019.
Read more below.
It is likely the Common Rule revisions will affect you in some way. The IRB Office is working to identify policies, procedures, applications as well as our standard operating procedures to see what needs to be modified and how to make these changes in accordance with the January 20, 2019 deadline.
Here is a summary of the things we are working on and how they may affect your interactions with the IRB office.
In the meantime it would be good for you to familiarize yourself with the Revised Common Rule.
Single IRBs for multisite research ("cooperative research?" (46.114)
External IRBs (46.103)
Checking the box (46.101)
Continuing review (46.109 & 46.115)
New language/clarity (46.116)
Basic and additional elements of informed consent (46.116)
Broad consent (46.111 & 46.116)
Recruitment/screening waivers (46.116)
Clinical trials consent forms (46.116)
Electronic consent (46.117)
Legally authorized representatives (46.102)
Definition: Research (46.102)
Definition: Human subjects (46.102)
Definition: Clinical trial (46.102)
Definition: Identifiable biospecimen/identifiable private information (46.102)
Definition: Vulnerable populations (46.111)
Tribal law (46.101, 46.114, 446.116)
Additional exemptions for low-risk studies (46.104- see also 46.103, 46.109, 46.110, 46.111)
1 year (1/19/18), 3 years for multisite (1/20/20) (46.101)